TY - JOUR
KW - 3340:Clinical Psychopharmacology
KW - Adulthood (18 yrs & older)
KW - article
KW - buprenorphine
KW - clinical outcomes
KW - cocaine
KW - Drug Therapy
KW - Drug Usage Screening
KW - Empirical Study
KW - Female
KW - Human
KW - Longitudinal Study
KW - Male
KW - monitoring
KW - norbuprenorphine level
KW - Quantitative Study
KW - Retrospective Study
KW - Treatment Outcomes
KW - urine drug screen
KW - US
AU - Ayman Fareed
AU - Kelly Scheinberg
AU - Sreedevi Vayalapalli
AU - Steven Stout
AU - Robin Gale
AU - Aalok Chandora
AU - Karen Drexler
A1 - 
BT - Addictive Disorders & Their Treatment
C5 - Opioids & Substance Use
CP - 4
IS - 4
JF - Addictive Disorders & Their Treatment
PB - Lippincott Williams & Wilkins
PY - 2013
SN - 1531-5754, 1531-5754
SP - 167
EP - 174
EP - 
T1 - Factors affecting norbuprenorphine level in monitoring clinical outcome for buprenorphine-maintained patients.
T2 - Addictive Disorders & Their Treatment
TI - Factors affecting norbuprenorphine level in monitoring clinical outcome for buprenorphine-maintained patients.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/1492677962?accountid=28100
VL - 12
VO - 1531-5754, 1531-5754
Y1 - 2013
ER -